Benitec Biopharma Statistics

Total Valuation

BNTC has a market cap or net worth of $354.25 million. The enterprise value is $276.10 million.

Market Cap	354.25M
Enterprise Value	276.10M

Important Dates

The next estimated earnings date is Monday, May 12, 2025, before market open.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BNTC has 25.49 million shares outstanding. The number of shares has increased by 451.89% in one year.

Current Share Class	25.49M
Shares Outstanding	25.49M
Shares Change (YoY)	+451.89%
Shares Change (QoQ)	+107.39%
Owned by Insiders (%)	5.94%
Owned by Institutions (%)	36.46%
Float	12.13M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	4.29
P/TBV Ratio	4.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 25.48, with a Debt / Equity ratio of 0.00.

Current Ratio	25.48
Quick Ratio	25.34
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -46.85% and return on invested capital (ROIC) is -32.74%.

Return on Equity (ROE)	-46.85%
Return on Assets (ROA)	-29.99%
Return on Invested Capital (ROIC)	-32.74%
Return on Capital Employed (ROCE)	-31.71%
Revenue Per Employee	n/a
Profits Per Employee	-$1.34M
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +101.17% in the last 52 weeks. The beta is 0.77, so BNTC's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	+101.17%
50-Day Moving Average	12.94
200-Day Moving Average	10.83
Relative Strength Index (RSI)	56.09
Average Volume (20 Days)	51,084

Short Selling Information

Short Interest	294,203
Short Previous Month	216,131
Short % of Shares Out	1.15%
Short % of Float	2.43%
Short Ratio (days to cover)	5.10

Income Statement

Revenue	n/a
Gross Profit	3,000
Operating Income	-24.09M
Pretax Income	-21.69M
Net Income	-21.42M
EBITDA	-24.00M
EBIT	-24.09M
Earnings Per Share (EPS)	-$1.94

Full Income Statement

Balance Sheet

The company has $78.28 million in cash and $137,000 in debt, giving a net cash position of $78.15 million or $3.07 per share.

Cash & Cash Equivalents	78.28M
Total Debt	137,000
Net Cash	78.15M
Net Cash Per Share	$3.07
Equity (Book Value)	75.94M
Book Value Per Share	3.24
Working Capital	75.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$21.75 million and capital expenditures -$191,000, giving a free cash flow of -$21.94 million.

Operating Cash Flow	-21.75M
Capital Expenditures	-191,000
Free Cash Flow	-21.94M
FCF Per Share	-$0.86

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BNTC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-451.89%
Shareholder Yield	n/a
Earnings Yield	-6.05%
FCF Yield	-6.19%

Dividend Details

Analyst Forecast

The average price target for BNTC is $24.71, which is 79.06% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$24.71
Price Target Difference	79.06%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 26, 2023. It was a reverse split with a ratio of 0.0588235:1.

Last Split Date	Jul 26, 2023
Split Type	Reverse
Split Ratio	0.0588235:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1